Increased anti-Xa bioavailability for a low molecular weight heparin (PK 10169) compared with unfractionated heparin.
D000328:Adult; D005170:Factor X / Q000037:antagonists & inhibitors; D015951:Factor Xa; D006493:Heparin / Q000008:administration & dosage / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008297:Male; D008970:Molecular Weight; D010314:Partial Thromboplastin Time; D011516:Prothrombin / Q000037:antagonists & inhibitors
D011516:Prothrombin; D005170:Factor X; C025337:Factor IIa; D006493:Heparin; D015951:Factor Xa